SE8404707D0 - Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav - Google Patents

Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav

Info

Publication number
SE8404707D0
SE8404707D0 SE8404707A SE8404707A SE8404707D0 SE 8404707 D0 SE8404707 D0 SE 8404707D0 SE 8404707 A SE8404707 A SE 8404707A SE 8404707 A SE8404707 A SE 8404707A SE 8404707 D0 SE8404707 D0 SE 8404707D0
Authority
SE
Sweden
Prior art keywords
extract
insulated
composition containing
detoxified endotoxin
containing pyridine
Prior art date
Application number
SE8404707A
Other languages
English (en)
Other versions
SE8404707L (sv
Inventor
J L Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of SE8404707D0 publication Critical patent/SE8404707D0/sv
Publication of SE8404707L publication Critical patent/SE8404707L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
SE8404707A 1983-09-23 1984-09-20 Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav SE8404707L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
SE8404707D0 true SE8404707D0 (sv) 1984-09-20
SE8404707L SE8404707L (sv) 1985-03-24

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404707A SE8404707L (sv) 1983-09-23 1984-09-20 Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav

Country Status (23)

Country Link
US (1) US4663306A (sv)
JP (1) JPS60120817A (sv)
KR (1) KR870000843B1 (sv)
AT (1) AT385659B (sv)
AU (1) AU566234B2 (sv)
BE (1) BE900650A (sv)
CA (1) CA1244765A (sv)
CH (1) CH664897A5 (sv)
DE (1) DE3434766A1 (sv)
DK (1) DK446684A (sv)
ES (1) ES8608872A1 (sv)
FI (1) FI843716L (sv)
FR (1) FR2552326B1 (sv)
GB (1) GB2149301B (sv)
HU (1) HU192585B (sv)
IL (1) IL73034A (sv)
IN (1) IN157240B (sv)
IT (1) IT1179444B (sv)
NL (1) NL8402902A (sv)
NO (1) NO843776L (sv)
NZ (1) NZ209635A (sv)
SE (1) SE8404707L (sv)
ZA (1) ZA847405B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
AU7488794A (en) * 1993-08-27 1995-03-21 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
JP4335435B2 (ja) 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
WO2000003724A1 (fr) * 1998-07-16 2000-01-27 Hayashi, Akira Preparations pour immunotherapie anticancereuse comprenant un constituant somatique bacterien en tant qu'ingredient actif
CA2393808A1 (en) * 1999-12-13 2001-06-21 Bioniche Life Sciences Inc. Anti-cancer synthetic oligonucleotides
DK1250152T3 (da) * 1999-12-28 2013-08-26 Bioniche Urology Ip Inc Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer
CZ200372A3 (cs) * 2000-07-11 2003-05-14 Bayer Aktiengesellschaft Použití kmenů Parapoxvirus ovis pro výrobu léku k léčení orgánových fibróz
AU2002236215B2 (en) * 2002-03-05 2008-03-06 Cell-Medicine, Inc. Solidified tissue immunological adjuvant
AU2003254792A1 (en) * 2002-08-02 2004-02-23 Sumitomo Pharmaceuticals Company, Limited Bacterial cell wall skeleton component preparaion
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
US20060127518A1 (en) * 2003-09-05 2006-06-15 Shenyang Sunbellcom Bio-Pharmaceutical Co. Red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
US20080032384A1 (en) * 2004-04-22 2008-02-07 Takehiko Nomura Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton
MX370573B (es) 2013-04-18 2019-12-17 Immune Design Corp Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
US10584344B2 (en) 2014-06-17 2020-03-10 Crown Laboratories, Inc. Genetically modified bacteria and methods for genetic modification of bacteria
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (sv) * 1972-06-20 1973-12-27
FR2269962B1 (sv) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
FI843716L (fi) 1985-03-24
IN157240B (sv) 1986-02-15
US4663306A (en) 1987-05-05
CH664897A5 (de) 1988-04-15
DK446684A (da) 1985-03-24
NO843776L (no) 1985-03-25
GB8423993D0 (en) 1984-10-31
BE900650A (fr) 1985-03-21
GB2149301B (en) 1988-06-22
HUT35521A (en) 1985-07-29
NL8402902A (nl) 1985-04-16
IL73034A (en) 1988-11-15
KR850002404A (ko) 1985-05-13
IT8448894A0 (it) 1984-09-24
FI843716A0 (fi) 1984-09-21
AT385659B (de) 1988-05-10
FR2552326A1 (fr) 1985-03-29
KR870000843B1 (ko) 1987-04-25
NZ209635A (en) 1989-01-27
AU566234B2 (en) 1987-10-15
IT1179444B (it) 1987-09-16
ATA302384A (de) 1987-10-15
DE3434766A1 (de) 1986-04-30
DK446684D0 (da) 1984-09-19
FR2552326B1 (fr) 1988-05-13
HU192585B (en) 1987-06-29
JPS6254775B2 (sv) 1987-11-17
SE8404707L (sv) 1985-03-24
ES8608872A1 (es) 1986-07-16
AU3340084A (en) 1985-03-28
ES536167A0 (es) 1986-07-16
CA1244765A (en) 1988-11-15
ZA847405B (en) 1985-05-29
JPS60120817A (ja) 1985-06-28
DE3434766C2 (sv) 1987-05-14
GB2149301A (en) 1985-06-12

Similar Documents

Publication Publication Date Title
SE8404707D0 (sv) Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav
IT8048102A0 (it) Procedimento di preparazione di un idrolisato di proteine purificato
DK173883D0 (da) Substituerede 8-phenylxanthiner
IT1127253B (it) Proteine purificate e procedimento per la loro preparazione
IT7968973A0 (it) Trinciatrice per la distruzione di documenti
ES499227A0 (es) Procedimiento para la determinacion de antigenos carcinoem- brionicos en el plasma humano
IT7924778A0 (it) Procedimento per l'innesto di particelle di gomma dienica in emulsione.
IT8723085A0 (it) Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse.
IT1126621B (it) Gabbia per stabulazione di animali e di topi in particolare
FR2550945B1 (fr) Compositions d'endotoxines purifiees et leur application pharmacologique
DE3750642D1 (de) Verfahren und Zusammensetzungen betreffend regressions-assoziierte Antigene.
IT8267822A0 (it) Procedimento per la preparazione di acril e metaacrilamidi n.sostituite
DE3262037D1 (de) 17-cyclopropylmethyl-3-hydroxy-14-methoxy 7 alpha-methylmorphinan-6-one
ES513956A0 (es) "procedimiento para la carbonilacion de olefinas y esteres organicos".
IT8125583A0 (it) Procedimento per l'estrazione di brodi di fermentazione nonfiltrati.
IT8125642A0 (it) Procedimento per la duplicazione di sagome e finiture.
IT1120568B (it) Trappola per topi e simili
PT85284A (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la co-ueluche contenant de telles fractions
ES273030Y (es) "dispositivo de union de muebles"
DK212083A (da) Antigenisk peptidforbindelse
IT1140348B (it) Procedimento per la preparazione di vaccino antitetanico
FR2511599B1 (fr) Vaccin anticoquelucheux
KR880010391U (ko) 한글문서작성 채점판
ES510096A0 (es) "procedimiento para la decoracion de vidrios y cristales".
ES234537Y (es) Disposicion de vitrina expositora.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8404707-5

Effective date: 19900401